RecruitingNot ApplicableNCT06316557
HOPE From the Cerebellum: TMS-Induced Cognitive Recovery After Stroke
Sponsor
Zi-Xiao Li
Enrollment
70 participants
Start Date
Jan 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The objective of this clinical trial is to investigate the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) in the cerebellum for individuals with post-stroke cognitive impairment. Participants will undergo rTMS in the cerebellar hemisphere opposite the lesion site, once daily for a total of five days.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- (1)ischemic stroke, with an initial incident occurring within 2 weeks;(2)MoCA<26;
Exclusion Criteria1
- (1)Cerebral hemorrhage or subarachnoid hemorrhage;(2)A pre-existing history of epilepsy;
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEiTBS group
iTBS on the contralesional cerebellum, twice a day for seven days
DEVICEcontrol group
shame stimulation on the contralesional cerebellum, twice a day for seven days
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06316557
Related Trials
Continuous Dual Aspiration Technique With Zoom System for Stroke
NCT074919529 locations
Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy
NCT0597668528 locations
Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke
NCT073579871 location
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
NCT0506521666 locations
Direct Ischemic Conditioning for Endovascular Recanalization for Anterior Large Vessel Occlusion (DICER-aLVO)
NCT069401281 location